Calmare Therapeutics Incorporated has appointed Stephen J. D Amato, M.D., F.A.C.E.P., chief medical officer (CMO) of Calmare Therapeutics. As part of Dr. D Amato's duties and responsibilities as the Company's chief medical officer and corporate executive, he will spearhead CTI's Centers of Excellence initiative. Dr. D Amato will continue to treat patients from his private practices in Rhode Island and forthcoming facility in Southwest Florida.

He will be available to all Calmare physicians and practitioners as a source of reference.